JP2005511632A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005511632A5 JP2005511632A5 JP2003545300A JP2003545300A JP2005511632A5 JP 2005511632 A5 JP2005511632 A5 JP 2005511632A5 JP 2003545300 A JP2003545300 A JP 2003545300A JP 2003545300 A JP2003545300 A JP 2003545300A JP 2005511632 A5 JP2005511632 A5 JP 2005511632A5
- Authority
- JP
- Japan
- Prior art keywords
- receptor agonist
- cannabinoid receptor
- medicament
- acceptable salt
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940121376 cannabinoid receptor agonist Drugs 0.000 claims 30
- 239000003537 cannabinoid receptor agonist Substances 0.000 claims 30
- 239000003814 drug Substances 0.000 claims 20
- 230000003287 optical effect Effects 0.000 claims 16
- 150000003839 salts Chemical class 0.000 claims 16
- 230000002265 prevention Effects 0.000 claims 10
- 238000004519 manufacturing process Methods 0.000 claims 8
- 238000010992 reflux Methods 0.000 claims 7
- 208000006673 asthma Diseases 0.000 claims 6
- 208000019693 Lung disease Diseases 0.000 claims 4
- 208000021302 gastroesophageal reflux disease Diseases 0.000 claims 4
- 229930003827 cannabinoid Natural products 0.000 claims 3
- 239000003557 cannabinoid Substances 0.000 claims 3
- 208000037824 growth disorder Diseases 0.000 claims 3
- 201000008197 Laryngitis Diseases 0.000 claims 2
- SCJNCDSAIRBRIA-DOFZRALJSA-N arachidonyl-2'-chloroethylamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCCl SCJNCDSAIRBRIA-DOFZRALJSA-N 0.000 claims 2
- 201000009243 chronic laryngitis Diseases 0.000 claims 2
- 210000000111 lower esophageal sphincter Anatomy 0.000 claims 2
- 230000035764 nutrition Effects 0.000 claims 2
- 235000016709 nutrition Nutrition 0.000 claims 2
- 230000001052 transient effect Effects 0.000 claims 2
- GLGAUBPACOBAMV-CGRWFSSPSA-N (5e,8e,11e,14e)-n-cyclopropylicosa-5,8,11,14-tetraenamide Chemical compound CCCCC\C=C\C\C=C\C\C=C\C\C=C\CCCC(=O)NC1CC1 GLGAUBPACOBAMV-CGRWFSSPSA-N 0.000 claims 1
- 102000009132 CB1 Cannabinoid Receptor Human genes 0.000 claims 1
- 108010073366 CB1 Cannabinoid Receptor Proteins 0.000 claims 1
- 102000009135 CB2 Cannabinoid Receptor Human genes 0.000 claims 1
- 108010073376 CB2 Cannabinoid Receptor Proteins 0.000 claims 1
- HQVHOQAKMCMIIM-HXUWFJFHSA-N WIN 55212-2 Chemical group C([C@@H]1COC=2C=CC=C3C(C(=O)C=4C5=CC=CC=C5C=CC=4)=C(N1C3=2)C)N1CCOCC1 HQVHOQAKMCMIIM-HXUWFJFHSA-N 0.000 claims 1
- LGEQQWMQCRIYKG-DOFZRALJSA-N anandamide Chemical group CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO LGEQQWMQCRIYKG-DOFZRALJSA-N 0.000 claims 1
- LGEQQWMQCRIYKG-UHFFFAOYSA-N arachidonic acid ethanolamide Natural products CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCO LGEQQWMQCRIYKG-UHFFFAOYSA-N 0.000 claims 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229960004242 dronabinol Drugs 0.000 claims 1
- 125000002250 eicosanoid group Chemical group 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 210000003736 gastrointestinal content Anatomy 0.000 claims 1
- 230000009548 growth disturbance Effects 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229950000251 nantradol Drugs 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103936 | 2001-11-23 | ||
| PCT/SE2002/002108 WO2003043619A1 (en) | 2001-11-23 | 2002-11-20 | New use for the treatment of gastroesophageal reflux disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005511632A JP2005511632A (ja) | 2005-04-28 |
| JP2005511632A5 true JP2005511632A5 (enExample) | 2006-01-12 |
Family
ID=20286096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003545300A Pending JP2005511632A (ja) | 2001-11-23 | 2002-11-20 | 胃食道逆流疾患の治療のための新しい使用 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7358245B2 (enExample) |
| EP (1) | EP1453497A1 (enExample) |
| JP (1) | JP2005511632A (enExample) |
| KR (1) | KR20050044582A (enExample) |
| CN (1) | CN1610542A (enExample) |
| AR (1) | AR037299A1 (enExample) |
| AU (1) | AU2002353700A1 (enExample) |
| BR (1) | BR0214319A (enExample) |
| CA (1) | CA2466916A1 (enExample) |
| HU (1) | HUP0402080A3 (enExample) |
| IL (1) | IL161748A0 (enExample) |
| IS (1) | IS7272A (enExample) |
| MX (1) | MXPA04004774A (enExample) |
| NO (1) | NO20042613L (enExample) |
| NZ (1) | NZ532844A (enExample) |
| PL (1) | PL369402A1 (enExample) |
| RU (1) | RU2280443C2 (enExample) |
| TW (1) | TW200407110A (enExample) |
| WO (1) | WO2003043619A1 (enExample) |
| ZA (1) | ZA200403785B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004283056A1 (en) * | 2003-10-24 | 2005-05-06 | Solvay Pharmaceuticals Gmbh | Novel medical uses of compounds showing CB1-antagonistic activity and combination treatment involving said compounds |
| WO2005060971A1 (en) * | 2003-12-18 | 2005-07-07 | Astrazeneca Ab | Treatment of reflux-related diseases |
| SE0303490D0 (sv) * | 2003-12-19 | 2003-12-19 | Astrazeneca Ab | New use V |
| WO2006045799A2 (en) | 2004-10-25 | 2006-05-04 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions |
| KR20070118069A (ko) * | 2004-12-09 | 2007-12-13 | 인시스 테라퓨틱스, 인코포레이티드 | 실온에서 안정한 드로나비놀 제형 |
| US20080112895A1 (en) * | 2006-08-04 | 2008-05-15 | Insys Therapeutics Inc. | Aqueous dronabinol formulations |
| JP2010535774A (ja) * | 2007-08-06 | 2010-11-25 | インシス セラピューティクス インコーポレイテッド | 経口カンナビノイド液体製剤および治療方法 |
| JP2010540618A (ja) * | 2007-10-02 | 2010-12-24 | アリエル−ユニバーシティー リサーチ アンド デベロップメント カンパニー リミテッド | 幼児の成長および発達を増大するための内在性カンナビノイド |
| US20090208588A1 (en) * | 2008-02-19 | 2009-08-20 | Roger Wayne Brown | GERD carbohydrate compositions |
| CN103588672A (zh) * | 2013-10-28 | 2014-02-19 | 史克勇 | 一种治疗癌性疼痛的药物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2735774B1 (fr) | 1995-06-21 | 1997-09-12 | Sanofi Sa | Utilisation de composes agonistes du recepteur cb2 humain pour la preparation de medicaments immunomodulateurs, nouveaux composes agonistes du recepteur cb2 et les compositions pharmaceutiques les contenant |
| US6017919A (en) * | 1996-02-06 | 2000-01-25 | Japan Tobacco Inc. | Compounds and pharmaceutical use thereof |
| US5939429A (en) * | 1997-09-30 | 1999-08-17 | Virginia Commonwealth University | Cardiovascular uses of cannabinoid compounds |
| ATE247097T1 (de) * | 1998-05-04 | 2003-08-15 | Univ Connecticut | Analgetische und immunomodulierende cannabinoiden |
| JP4817495B2 (ja) * | 1998-05-29 | 2011-11-16 | ニューロサイエンシーズ・リサーチ・ファウンデーション・インコーポレーテッド | 外因性カンナビノイドでの痛みの制御 |
| GB9923738D0 (en) * | 1999-10-07 | 1999-12-08 | Nestle Sa | Nutritional composition |
| IL132661A (en) * | 1999-10-31 | 2008-11-26 | Raphael Mechoulam | Agonists specific for peripheral cannabinoid receptors |
| SE9904507D0 (sv) | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
| TWI302913B (en) * | 2000-06-15 | 2008-11-11 | Schering Corp | Thrombin receptor antagonists |
| AUPR118000A0 (en) | 2000-11-02 | 2000-11-23 | Amrad Operations Pty. Limited | Therapeutic molecules and methods |
| FR2816938B1 (fr) * | 2000-11-22 | 2003-01-03 | Sanofi Synthelabo | Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant |
| US20020077322A1 (en) | 2000-12-15 | 2002-06-20 | Ayoub George S. | Protection of neurons against glutamate-induced damage in glaucoma and other conditions |
-
2002
- 2002-11-07 TW TW091132760A patent/TW200407110A/zh unknown
- 2002-11-11 AR ARP020104319A patent/AR037299A1/es not_active Application Discontinuation
- 2002-11-20 NZ NZ532844A patent/NZ532844A/en unknown
- 2002-11-20 WO PCT/SE2002/002108 patent/WO2003043619A1/en not_active Ceased
- 2002-11-20 CA CA002466916A patent/CA2466916A1/en not_active Abandoned
- 2002-11-20 KR KR1020047007819A patent/KR20050044582A/ko not_active Withdrawn
- 2002-11-20 US US10/496,431 patent/US7358245B2/en not_active Expired - Fee Related
- 2002-11-20 PL PL02369402A patent/PL369402A1/xx unknown
- 2002-11-20 CN CNA028233514A patent/CN1610542A/zh active Pending
- 2002-11-20 RU RU2004114843/15A patent/RU2280443C2/ru not_active IP Right Cessation
- 2002-11-20 AU AU2002353700A patent/AU2002353700A1/en not_active Abandoned
- 2002-11-20 BR BR0214319-4A patent/BR0214319A/pt not_active IP Right Cessation
- 2002-11-20 MX MXPA04004774A patent/MXPA04004774A/es not_active Application Discontinuation
- 2002-11-20 HU HU0402080A patent/HUP0402080A3/hu unknown
- 2002-11-20 IL IL16174802A patent/IL161748A0/xx unknown
- 2002-11-20 JP JP2003545300A patent/JP2005511632A/ja active Pending
- 2002-11-20 EP EP02789069A patent/EP1453497A1/en not_active Withdrawn
-
2004
- 2004-05-17 ZA ZA200403785A patent/ZA200403785B/en unknown
- 2004-05-19 IS IS7272A patent/IS7272A/is unknown
- 2004-06-22 NO NO20042613A patent/NO20042613L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105007947B (zh) | 固溶体组合物及其在心血管疾病中的用途 | |
| JP2011068669A (ja) | Ｇｅｒｄの治療のためのｍｇｌｕｒ５アンタゴニストの使用 | |
| US20110237563A1 (en) | Fast dissolving drug delivery systems | |
| JP5712452B2 (ja) | 診断された呼吸疾患を有する患者もしくは診断未確定の呼吸疾患を有する患者におけるオピオイド鎮痛薬の投与に関連する危険性を減少するための方法および組成 | |
| JP2005511632A5 (enExample) | ||
| WO2007070504A2 (en) | Stable and palatable oral liquid sumatriptan compositions | |
| TW201912153A (zh) | 用於治療ｂ型肝炎的化合物、醫藥組合物及方法 | |
| CN101939001B (zh) | 用于治疗卵巢癌的含有紫杉醇的组合 | |
| WO2022182658A1 (en) | Use of aprepitant for treating alzheimer's disease | |
| JP2007512273A (ja) | ベータ−３−アドレノセプター作用薬及びプロスタグランジン代謝に影響を及ぼす活性物質から成る医薬組成物 | |
| US10682343B2 (en) | Snoring treatment | |
| US20050101607A1 (en) | Pharmaceutical composition containing a beta-3-adrenoceptor agonist and an alpha antagonist and/or a 5-alpha reductase inhibitor | |
| RU2004114843A (ru) | Новое применение для лечения заболеваний гастроэзофагеальной рефлюксной болезни | |
| KR20020070525A (ko) | 디아미노트리플루오로메틸피리딘의 유도체를 함유하는소화기 질환 치료제 또는 예방제 | |
| JP6370801B2 (ja) | 肝疾患または肝障害の治療のための使用および方法 | |
| JP5042625B2 (ja) | 抗炎症剤として有用なα−アミノアミド誘導体 | |
| CN107073015A (zh) | 用于治疗吸烟者中的非小细胞肺癌的维利帕尼与卡铂和紫杉醇的组合 | |
| CA2464309A1 (en) | Combinations comprising a selective cyclooxygenase-2 inhibitor | |
| US20050154041A1 (en) | Pharmaceutical composition consisting of a beta-3-adrenoceptor agonist and alpha-agonist | |
| US20080207667A1 (en) | Use of nalbuphine and related compounds to treat symptoms of respiratory problems | |
| AU2007325972A1 (en) | S-nitrosothiol compounds and related derivatives | |
| CN101291660A (zh) | 恢复正常呼吸节律的基于s-亚硝基硫醇的复方药品 | |
| CN107496426A (zh) | 含伊马替尼或其药学上可接受的盐作为有效成分的用于治疗或预防血管渗透性疾病的组合物 | |
| JP2024515891A (ja) | 情緒障害の処置のためのケタミン及びカンナビス | |
| CN106822158B (zh) | 红景天苷用于防治阻塞性睡眠呼吸暂停诱导型高血压 |